TY - JOUR
T1 - Novel 3-amino-acid-length endothelins cause constriction of vascular smooth muscle
AU - Kishi, Fumiko
AU - Minami, Kazushi
AU - Okishima, Naoko
AU - Murakami, Meiko
AU - Mori, Sachie
AU - Yano, Mihiro
AU - Niwa, Yasuharu
AU - Nakaya, Yutaka
AU - Kido, Hiroshi
PY - 1998/7/20
Y1 - 1998/7/20
N2 - We have reported that human chymase specifically cleaves big endothelins (ETs) at the Try31-Gly32 bond, and produces novel trachea-constricting 31-amino-acid-length ETs, ETs(1-31). In this study, we investigated the effect of synthetic ETs(1-31) on the contractile activity toward porcine coronary arteries and rat aortae. Although ETs(1-31) exhibited less potent vasoconstrictile activity in these tissues than 21-amino-acid-length ETs(1-21), or a similar extent, ET-1(1-31) caused significantly slower-developing and longer-lasting contraction than ETs(1-21). The ET(A) receptor antagonist, BQ485, completely inhibited the activity of ET-1(1-31). The ET(B) receptor antagonist, BQ788, also inhibited the activity of ET-1(1-31) toward rat aortae more efficiently than that ET-1(1-21). Therefore, trachea-constricting peptides ETs(1-31) play roles as vasoconstrictors in a different manner from ETs(1-21).
AB - We have reported that human chymase specifically cleaves big endothelins (ETs) at the Try31-Gly32 bond, and produces novel trachea-constricting 31-amino-acid-length ETs, ETs(1-31). In this study, we investigated the effect of synthetic ETs(1-31) on the contractile activity toward porcine coronary arteries and rat aortae. Although ETs(1-31) exhibited less potent vasoconstrictile activity in these tissues than 21-amino-acid-length ETs(1-21), or a similar extent, ET-1(1-31) caused significantly slower-developing and longer-lasting contraction than ETs(1-21). The ET(A) receptor antagonist, BQ485, completely inhibited the activity of ET-1(1-31). The ET(B) receptor antagonist, BQ788, also inhibited the activity of ET-1(1-31) toward rat aortae more efficiently than that ET-1(1-21). Therefore, trachea-constricting peptides ETs(1-31) play roles as vasoconstrictors in a different manner from ETs(1-21).
UR - http://www.scopus.com/inward/record.url?scp=0032551304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032551304&partnerID=8YFLogxK
U2 - 10.1006/bbrc.1998.8980
DO - 10.1006/bbrc.1998.8980
M3 - Article
C2 - 9675146
AN - SCOPUS:0032551304
SN - 0006-291X
VL - 248
SP - 387
EP - 390
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -